Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Robert Hershberg | President and Chief Executive Officer | 2025-02-11 | 11,901 | $1.77 | $21.01kSell |
Shane Maltbie | Chief Financial Officer | 2025-02-11 | 4,345 | $1.76 | $7.66kSell |
Robert Hershberg | President and Chief Executive Officer | 2025-02-04 | 14,634 | $1.89 | $27.66kSell |
Shane Maltbie | Chief Financial Officer | 2025-02-04 | 3,946 | $1.89 | $7.46kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Frazier Life Sciences Management LP | 21.17% | 10,617,062 | $22.19M | Institution |
Patrick J. Heron | 17.06% | 8,552,536 | $17.87M | Insider |
Frazier Life Sciences X LP | 17.02% | 8,535,337 | $17.84M | Insider |
Takeda Pharmaceutical Co Ltd | 13.41% | 6,724,000 | $14.05M | Insider |
Takeda Pharmaceutical Co Ltd | 13.41% | 6,724,000 | $14.05M | Institution |
Tang Capital Management LLC | 9.81% | 4,920,000 | $10.28M | Institution |
Ecor1 Capital LLC | 4.83% | 2,420,243 | $5.06M | Institution |
Lightspeed Management Company LLC | 4.59% | 2,303,871 | $4.82M | Institution |
Franklin Resources Inc | 3.90% | 1,953,642 | $4.08M | Institution |
Deerfield Management Company LP | 3.75% | 1,882,654 | $3.93M | Institution |